EVH: Evolent Health, Inc. - Summary | Jitta

Evolent Health, Inc.

NYSE:EVH

Price
$4.18
Loss Chance
46.1%
3.15JITTA SCORE
82.80%Under Jitta Line
Jitta Ranking
183 / 719
1,827 / 4,226
Grow your money with Jitta Ranking. See details.
HISTORICAL JITTA SCORE
Jitta Factors
Growth Opportunity (44)
Recent Business Performance (22)
Financial Strength (44)
Return to Shareholders (7)
Competitive Advantage (37)
Jitta Signs
SG&A to SalesDecreasing
Cash Conversion CycleLess than 60 days
Revenue and EarningEarning loss detected in 2021
Operating MarginDeclined
Debt LevelVery High Long Term Debt
Recent Business PerformanceEarning decline 51.54% in the last year
Key Stats
Jitta Score
Jitta Line
3.15
82.80%
3.05
138.31%
Health Care Technology
6.06
14.07%
4.17
93.78%
6.63
43.12%
COMPANY DESCRIPTION
Evolent Health, Inc., through its subsidiary, provides specialty care management services in oncology, cardiology, and musculoskeletal markets in the United States. The company offers integrated value-based care platform for health plan administration and management. It also provides administrative services, such as health plan services, pharmacy benefits management, risk management, analytics and reporting, and leadership and management; and Identifi, a proprietary technology system that aggregates and analyzes data, manages care workflows, and engages patients. In addition, the company provides Machinify Auth Intelligence, an artificial intelligence tool to aid nurses and physicians in completing clinical review of prior authorization requests. Evolent Health, Inc. was founded in 2011 and is headquartered in Arlington, Virginia.